This article has Open Peer Review reports available.
Analysis of human alveolar osteoblast behavior on a nano-hydroxyapatite substrate: an in vitro study
© Pilloni et al.; licensee BioMed Central Ltd. 2014
Received: 27 November 2013
Accepted: 17 March 2014
Published: 20 March 2014
Nano-hydroxyapatite (nHA) is a potential ideal biomaterial for bone regeneration. However, studies have yet to characterize the behavior of human osteoblasts derived from alveolar bone on nHA. Thus, the aim of the present study was to evaluate the influence of nHA on the adhesion, proliferation and differentiation of these alveolar bone-derived cells.
Primary human alveolar osteoblasts were collected from the alveolar ridge of a male periodontal patient during osseous resective surgery and grown on culture plates coated with either polylysine or polylysine with nano-hydroxyapatite (POL/nHA) composite. The cells were grown and observed for 14 days, and then assessed for potential modifications to osteoblasts homeostasis as evaluated by quantitative reverse transcriptase-polymerase chain reaction (real time RT-PCR), scanning electron microscopy and atomic force microscopy.
Real time PCR revealed a significant increase in the expression of the selected markers of osteoblast differentiation (bone morphogenetic protein (BMP)-2,-5,-7, ALP, COLL-1A2, OC, ON) in cells grown on the POL/nHA substrate. In addition, as compared with the POL surface, cells grown on the POL/nHA substrate demonstrated better osteoconductive properties, as demonstrated by the increase in adhesion and spreading, likely as a result of the increased surface roughness of the composite.
The increased expression of BMPs and osteoinductive biomarkers suggest that nano-hydroxyapatite may stimulate the proliferation and differentiation of local alveolar osteoblasts and thus encourage bone regeneration at sites of alveolar bone regeneration.
The main concern of periodontology is the rehabilitation of periodontally compromised teeth, possibly aiming at the complete periodontal tissue regeneration . Ideally, this process would include the formation of new bone, new periodontal ligament and new cementum, or rather a new attachment over the root that has previously been deprived of all the attachment apparatus . The therapeutic approaches attempting to achieve this objective include the use of different grafting materials (autogenous, allogeneic, xenogeneic and alloplastic grafts), physical barriers for Guided Tissue Regeneration (GTR), enamel matrix-derived proteins, and various growth factors [3, 4].
It is assumed that the use of bone grafts or alloplastic materials would result both in the regrowth of alveolar bone and the formation of a new cementum layer with inserted collagen fibers onto the previously periodontitis-involved root surface . The mechanism of action may be either via the stimulation of osteogenesis (new bone formation from the bone-forming cells contained in the graft), osteoconduction (when the graft serves as a scaffold for bone formation from the adjacent host bone), or osteoinduction (the matrix of the bone graft contains bone-inducing substances that result in bone formation in the surrounding tissues even if not bone tissue) . Alloplastic materials are presumed to promote bone healing through osteoconduction and subsequently behave as a scaffold for this process .
An ideal scaffold is a biocompatible material that provides appropriate mechanical support . It should possess a structure similar to the native extracellular matrix, exhibit favorable surface properties, and lead to an increase in adhesion, proliferation and differentiation of osteoblastic cells . Hydroxyapatite (HA) [Ca5 (PO4)3 OH] is an alloplastic material, chemically similar to the inorganic component of bone matrix that translates these properties in a valuable and optimal biocompatibility . When HA is grafted beneath a healthy periosteum and well-vascularized bone, it first becomes integrated by a clot  and then releases phosphate ions into the surrounding environment, which stimulates neo-osteogenesis.
A fundamental factor governing optimal integration of HA with bone is the dimensions of the crystals. HA particles with dimensions closer to the size of natural crystals found in vertebrate hard tissues (i.e., ranging from 1 to 10 nm), are now available , and they have been reported to mimic the extracellular matrix of bone in size and structure . In vitro studies conducted with the purpose of understanding the mechanism of action of this nano-sized material have described a stimulatory effect on mesenchymal stem cells , an increase in protein absorption and osteoblast adhesion as compared with traditional micro-sized HA [12, 13], stimulation of human osteoblast-like cell proliferation resulting in bone formation , and the stimulation of PDL cell attachment . Despite this, there is little information to date regarding the responses of human alveolar osteoblasts in contact with this grafting material once the bone defect is filled. Thus, the aim of our study was to evaluate in vitro the effects of nHA on the adhesion and proliferation of human alveolar osteoblasts and to determine the impact that this alloplastic material has on the expression of biomarkers of bone formation during HA-mediated periodontal bone regeneration.
Isolation of human primary osteoblasts
Fresh human bone removed from the alveolar crest were obtained with approval from the Ethical Committee of Sapienza University of Rome and informed patient consent.
Harvested bone specimens were stored in Hank’s Balanced Salt Solution (HBSS, Sigma-Aldrich, St. Louis, MO) containing 100 U/ml penicillin and 100 mg/ml streptomycin until processing. For processing, bone samples were rinsed in sterile phosphate-buffered saline (PBS), pH 7.4, fragmented with a scalpel, and digested in solution of 1 mg/ml type IV collagenase and 0.25% trypsin (in PBS) at 37°C for 30 min with agitation, followed two additional digestion stages for 40 min and 90 min, as previously described [18, 19]. Cells obtained from the second and third digestions were collected, centrifuged and resuspended in Dulbecco’s Modified Eagles Medium (DMEM, Gibco-BRL, Rockville, MD) supplemented with 50 U/ml penicillin, 50 μg/ml streptomycin, 4 mmol/l L-glutamine and 10% of fetal bovine serum (FBS, Hyclone, Thermo Scientific, Wilmington, DE). Cells adhesion, proliferation and morphology were visually inspected by microscopy (Nikon Eclipse TS100, Nikon, Tokyo, Japan) over the 2-week time frame. After the cells reached 70-80% confluence, they were detached with trypsin-EDTA, harvested and used for experiments between passages 2 and 4.
Poly-L-lysine and Poly-L-lysine-nHA coating preparation
One milliliter per 25 cm2 of 0.01% poly-L-lysine solution (POL, Bioreagent, mol wt 150,000-300,000, sterile-filtered, Sigma-Aldrich) was used to coat the surfaces of Petri plates. Samples were gently shaken at 4°C at 1200 rpm for 10 min to homogenize stratification. The surfaces were then rinsed with sterile water and allowed to dry at room temperature. Subsequently, 10 mg of nHA powder (Ghimas Spa, Casalecchio di Reno, BO, Italy) was resuspended in 1 ml of sterile water and used to coat the POL-treated plates. Finally, coated surfaces were rinsed with sterile water and allowed to dry.
Osteoblasts-POL and osteoblasts-POL-nHA samples preparation
Osteoblast behavior was examined on coated plates using two tests: in Test 1, plates coated only with POL were seeded with hOBs onto at a density of 2 × 104 cells/cm2; in Test 2, hOBs were seeded at the same density onto plates coated with POL and nHA powder. Samples of Test 1 and Test 2 were cultured under the same experimental conditions (95% humidity, 5% CO2, 37°C) in DMEM containing 10% FBS. Experiments were performed in triplicate and repeated three times each.
Scanning electron microscopy
Surface properties of the coated plates and osteoblast morphology were visually investigated by scanning electron microscopy (SEM). After 24 h of culture on POL or POL-nHA coated surfaces, samples were rinsed twice with PBS, fixed in 2.5% glutaraldehyde for 1 h, rinsed with distilled water, dehydrated with graded concentrations of alcohol (50%, 70%, 90%, 100% ethanol) and finally treated with CO2 at the top-critical point. Specimens were fixed onto aluminum stubs using a conductive carbon tape and then coated with a 10-nm gold layer (Coating Unit E5000, Polaron Ltd. Watford, UK). Specimens were observed with SEM (Leo 1450VP, Carl Zeiss, Jena, Germany) at various magnifications, using secondary electrons at 15 kV.
Atomic force microscopy
Atomic force microscopy (AFM) was carried out using a Nanonics Imaging AFM system (Jerusalem, Israel) in a no contact mode and a reference voltage of 0.8–1.0 V between the tip and the sample surface during all experiments.
Human primers used in RT-PCR for Glyceraldehyde-3 phosphate-dehydrogenase (GAPDH), alkaline phosphatase (ALP), A2 pro-collagen type 1 chain (COLL-1A2), bone morphogenetic protein-2,-5,-7 (BMP-2,-5,-7)
Statistical analysis of data
The Statistical Package for Social Sciences (SPPS v15.0, SPSS Inc. Chicago, IL) was used for statistical analysis. Analyses were performed using Student’s t-test. Significance was set at p < 0.05.
Human primary osteoblasts extraction and culture
POL and POL-nHA surface roughness properties
Effect of nano-hydroxyapatite on osteoblast adhesion and proliferation
Effects of nano-hydroxyapatite on gene expression of human osteoblasts
Overall, our results show that, within a 14-day time frame, POL/nHA substrate can enhance the expression of specific osteoblastic genes, which strongly indicates a positive effect of nHA on osteoblast differentiation (Figure 4).
Hydroxyapatite, among the various bone grafting substitutes, has been widely investigated in periodontal regeneration over the past three decades [4, 20]. HA alloplastic grafts, despite their similar chemical composition to bone, are known mainly for their osteoconductive properties . Our study has confirmed the osteoconductive properties of a nano-sized version of this material, showing that nHA can stimulate osteoblasts to produce selected biomarkers representative of bone formation and mesenchymal cell recruitment.
The rationale for the choice of human alveolar osteoblasts is based on the fact that these cells are located on the bone surface of the defect, meaning that the grafted material will be in direct contact with these osteoblasts during healing. The cell collection method was performed using a bone scalpel as part of a well-documented technique used during resective periodontal surgery [21, 22]. Cell culture and formation of the substrates were performed followed models previously used (dispersion of particles of nHA in poli-ethylene-glicol-dimethacrylate or nHA associated with a polycarbonate, polyamide, polysaccharide) [23–27]. Human alveolar osteoblasts are the primary cells responsible for alveolar bone formation, although they do not appear to be able to migrate and proliferate at distant sites where bone regeneration is required. Albrektsson & Johansson suggested that pre-existing osteoblastic cells only contribute a minor portion of the new bone needed in a fracture healing situation and that the recruitment of immature cells and their differentiation into osteoblasts are probably the basic and pivotal mechanism regulating bone healing . Indeed, osteoblasts have been shown to contribute to the production of growth factors that encourage cellular migration as well as the osteogenic and chondrogenic differentiation of mesenchymal progenitor cells . Our study demonstrates that nHA stimulates the local alveolar osteoblasts to produce relevant bone-specific BMPs, which are known to initiate and regulate bone formation starting from the progenitor cells.
Several types of BMPs, which belong to the transforming growth factor (TGF)-β family, have been investigated and characterized for their modulatory role in bone tissue homeostasis. BMP-2 and BMP-7 are of particular interest, since they are naturally released in response to trauma or during bone remodeling and are, to date, the only known inductive agents . Stimulation of BMP-2, -5 and -7 is an important aspect of osteogenesis, as these proteins are the three of the most potent growth factors enhancing bone formation. The results presented herein show that nHA promotes BMP expression by alveolar osteoblasts in vitro. This observation suggests that nHA might act as promoter of bone regeneration at the bone defect site in two ways: by inducing osteogenic differentiation as observed by Lock et al.  and/or by inducing the secretion of specific factors, such as BMPs or other growth factors not tested in this experiment. Moreover, the nHA influenced a significant increase in the expression of several important markers of osteogenesis ALP, OC, ON and COLL-1A2.
To instigate bone formation, cells need to adhere and proliferate. Surface roughness is an important consideration when selecting a bone-inducing substrate. According to physical and mechanical principles, a substrate with superficial roughness shows a higher capacity for adhesion when compared with a smooth surface [29–32]. In this study, osteoblast adhesion was evaluated based on changes to the cell form and on the presence of filopodia. SEM and AFM images showed that nHA had a rougher surface than the control substrate and favored the adhesion and proliferation of human osteoblasts. These results are in agreement with those reported by Thian et al., showing that nHA enhanced adhesion and spreading of human osteoblast-like cells  and Liu et al., demonstrating the induction of adhesion and proliferation of human osteoblast-like MG-63 cells on nHA .
Within the limits of this study, we observed that nHA can significantly increase on site human alveolar osteoblast adhesion and differentiation, and therefore speculate that nHA could encourage bone formation by local osteoblasts at sites of alveolar bone reconstruction. In addition, the increased expression of BMPs on the nHA surface could indicate an increase in the recruitment of progenitor cells during healing with nHA scaffolds. These in vitro findings could explain, at least in part, the new bone formation witnessed in bone defects filled with nHA grafting material [34, 35] and suggest the further role of nHA in periodontal reattachment processes, including the formation of new cementum and new periodontal ligament. Further histological and clinical studies are needed to give significance to the in vitro results as well as a biological explanation of the clinical outcomes observed by others.
- Sculean A, Nikolidakis D, Schwarz F: Regeneration of periodontal tissues: combinations of barrier membranes and grafting materials – biological foundation and preclinical evidence. A systematic review. J Clin Periodontol. 2008, 35 (Suppl. 8): 106-116.View ArticlePubMedGoogle Scholar
- American Academy of Periodontology: Glossary of Periodontal Terms. 2001, Chicago: American Academy of Periodontology, 4Google Scholar
- Hi W, Varanasi S, Strounina E: American Academy of Periodontology position paper: periodontal regeneration. J Periodontol. 2005, 76: 1601-1622.View ArticleGoogle Scholar
- Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL: Regeneration of periodontal tissue: bone replacement grafts. Dent Clin North Am. 2010, 54: 55-71. 10.1016/j.cden.2009.09.003.View ArticlePubMedGoogle Scholar
- Karring TH: Concepts in Periodontal Tissue Regeneration. Clinical Periodontology and Implant Dentistry. Edited by: Lindhe J. 2008, New York: Wiley Blackwell, 548-556. 5Google Scholar
- Albrektsson T, Johansson C: Osteoinduction, osteoconduction and osseoinegration. Eur Spine J. 2001, 10: 96-101. 10.1007/s005860100282.View ArticleGoogle Scholar
- Zhou H, Lee J: Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater. 2011, 7: 2769-2781. 10.1016/j.actbio.2011.03.019.View ArticlePubMedGoogle Scholar
- Li Z, Yubao L, Aiping Y: Preparation and in vitro investigation of chitosan/nanohydroxyapatite composite used as bone substitute materials. J Mater Sci Mater Med. 2005, 16: 213-219. 10.1007/s10856-005-6682-3.View ArticlePubMedGoogle Scholar
- Bouyer E, Gitzhofer F, Boulos MI: Morphological study of hydroxyapatite nanocrystals suspension. J Mater Sci Mater Med. 2000, 11: 523-531. 10.1023/A:1008918110156.View ArticlePubMedGoogle Scholar
- Ngiam M, Nguyen LT, Liao S, Chan CK, Ramakrishna S: Biomimetic nanostructured materials — potential regulators for osteogenesis?. Ann Acad Med Singapore. 2011, 40: 213-222.PubMedGoogle Scholar
- Lock J, Liu H: Nanomaterials enhance osteogenic differentiation of human mesenchimal stem cells similar to a short peptide of BMP-7. Int J Nanomed. 2011, 6: 2769-2777.Google Scholar
- Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R: Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res. 2000, 51: 475-483. 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.0.CO;2-9.View ArticlePubMedGoogle Scholar
- Webster TJ, Siegel RW, Bizios R: Osteoblast adhesion on nanophase ceramics. Biomaterials. 1999, 20: 1221-1227. 10.1016/S0142-9612(99)00020-4.View ArticlePubMedGoogle Scholar
- Liu X, Zhao M, Lu J, Maa J, Wei J, Wei S: Cell responses to two kinds of nanohydroxyapatite with different sizes and crystallinities. In J Nanomed. 2012, 7: 1239-1250.View ArticleGoogle Scholar
- Kasaj A, Willershausen B, Reichert C, Röhring B, Smeets R, Schmidt M: Ability of nanocrystalline hydroxyapatite paste to promote human periodontal ligament cell prolifaration. J Oral Sci. 2008, 50 (Suppl. 3): 279-285.View ArticlePubMedGoogle Scholar
- Fragale A, Tartaglia M, Bernardini S, Di Stasi AMM, Di Rocco C, Velardi F: Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am J Pathol. 1999, 154 (Suppl. 5): 1465-1477.View ArticlePubMedPubMed CentralGoogle Scholar
- Taranta A, Brama M, Teti A, De Luca V, Scandurra R, Spera G, Agnusdei D, Termine JD, Migliaccio S: The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro. Bone. 2002, 30 (Suppl. 2): 368-376.View ArticlePubMedGoogle Scholar
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.View ArticlePubMedGoogle Scholar
- Pfaffl MW: A new mathematical model for relative quantification in real- time RT-PCR. Nucleic Acids Res. 2001, 29: 2002-2007.View ArticleGoogle Scholar
- Kenney EB, Lekovic V, Han T, Carranza FA, Dimitrijevic B: The use of a porous hydroxylapatite implant in periodontal defects. I. Clinical results after six months. J Periodontol. 1985, 56 (Suppl. 2): 82-88.View ArticlePubMedGoogle Scholar
- Ochsenbein C: Osseous resection in periodontology. J Periodontol. 1958, 29: 15-26. 10.1902/jop.19188.8.131.52.View ArticleGoogle Scholar
- Carnevale G, Kaldahl WB: Osseous resective surgery. Periodontology. 2000, 22: 59-87. 10.1034/j.1600-0757.2000.2220106.x.View ArticleGoogle Scholar
- Zhou Z, Ren Y, Yang D, Nie J: Performance improvement of injectable poly(ethylene glycol) dimethacrylate-based hydrogels with finely dispersed hydroxyapatite. J Biomed Mater. 2009, 4 (Suppl. 3): 3500-3507.Google Scholar
- Li J, Chen Y, Yin Y, Yao F, Yao K: Modulation of nano-hydroxyapatite size via formation on chitosan-gelatin network film in situ. Biomaterials. 2007, 28 (Suppl. 5): 781-790.View ArticlePubMedGoogle Scholar
- Wang H, Li Y, Zuo Y, Li J, Ma S, Cheng L: Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering. Biomaterials. 2007, 28 (Suppl. 22): 3338-3348.View ArticlePubMedGoogle Scholar
- Murugan R, Ramakrishna S: Bioresorbable composite bone paste using polysaccharide based nano hydroxyapatite. Biomaterials. 2004, 25 (Suppl. 17): 3829-3835.View ArticlePubMedGoogle Scholar
- Wei G, Ma PX: Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials. 2004, 25 (Suppl. 19): 4749-4757.View ArticlePubMedGoogle Scholar
- Giannobilie WV: Bone as a Tissue. Clinical Periodontology and Implant Dentistry. Edited by: Lindhe J. 2008, New York: Wiley Blackwell, 86-95. 5Google Scholar
- Keselowsky BG, Wang L, Schwartz Z, Garcia AJ, Boyan BD: Integrin alpha(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner. J Biomed Mater Res A. 2007, 80 (Suppl. 3): 700-710.View ArticlePubMedGoogle Scholar
- Yamashita D, Machigashira M, Miyamoto M, Takeuchi H, Noguchi K, Izumi Y, Ban S: Effect of surface roughness on initial responses of osteoblast-like cells on two types of zirconia. Dent Mater J. 2009, 28 (Suppl. 4): 461-470.View ArticlePubMedGoogle Scholar
- Klein MO, Bijelic A, Ziebart T, Koch F, Kämmerer PW, Wieland M, Konerding MA, Al-Nawas B: Submicron scale-structured hydrophilic titanium surfaces promote early osteogenic gene response for cell adhesion and cell differentiation. Clin Implant Dent Relat Res. 2011, 15 (Suppl. 2): 166-175.PubMedGoogle Scholar
- Boyan BD, Lossdörfer S, Wang L, Zhao G, Lohmann CH, Cochran DL, Schwartz Z: Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies. Eur Cell Mater. 2003, 24 (Suppl. 6): 22-27.Google Scholar
- Thian ES, Huang J, Ahmad Z, Edirisinghe MJ, Jayasinghe SN, Ireland DC: Influence of nanohydroxyapatite patterns deposited by electrohydrodynamic spraying on osteblast response. J Biomed Mater Res A. 2008, 85: 188-194.View ArticlePubMedGoogle Scholar
- Kasaj A, Röhring B, Zafiropoulos GG, Willershausen B: Clinical evaluation of nanocrystalline hydroxyapatite paste in the treatment of humen periodontal bony defects – a randomized controlled clinical trial: 6 months results. J Periodontol. 2008, 79: 394-400. 10.1902/jop.2008.070378.View ArticlePubMedGoogle Scholar
- Heinz B, Kasaj A, Teich M, Jepsen S: Clinical effects of nanocrystalline hydroxyapatite paste in the treatment of intrabony periodontal defects: a randomized controlled clinical study. Clin Oral Invest. 2010, 14: 525-531. 10.1007/s00784-009-0325-x.View ArticleGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6831/14/22/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.